Second quarter revenue grew 37% to $76 million Consumer revenue grew 27% year over year due to the addition of telehealth revenue On track to achieve FY2023 financial guidance SOUTH SAN FRANCISCO, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding …
Q3 2022 DANYELZA® record product revenues of $12.5 million, YoY growth of 40% and 28% sequential increase compared to Q2 2022 DANYELZA marketing authorization granted in Israel; regulatory filing submitted in Brazil Management reiterates financial guidance …
SAN DIEGO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate …
Company held end of Phase 2 meeting with FDA to discuss advancing oral AMT-101 monotherapy to Phase 3 in chronic pouchitis, an orphan indication with no FDA-approved products Anticipate Phase 2 top-line readout for oral AMT-101 in UC monotherapy in late …
RESEARCH TRIANGLE PARK, N.C., Nov. 07, 2022 (GLOBE NEWSWIRE) -- ChannelAdvisor Corporation (NYSE: ECOM), a leading provider of cloud-based e-commerce solutions that enable brands and retailers to increase global sales, today reported financial results for …
DELRAY BEACH, Fla., Nov. 07, 2022 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS), Your Trusted Pet Health ExpertTM, today announced its financial results for its second quarter ended September 30, 2022. Quarterly Highlights Net sales for the …
Q3 2022 revenue of $89.0 million, up 4% over Q3 2021 Net income of $3.1 million, or $0.04 per share Gross profit (exclusive of depreciation and amortization) of $23.8 million, an increase of 8% over Q3 2021 and representing 27% of revenue for the three …
Continued advancement of pamrevlumab clinical trials – topline data from five pivotal Phase 3 trials beginning in 1H 2023 through mid-2024 Completed enrollment of MATTERHORN Phase 3 study of roxadustat in patients with anemia of myelodysplastic syndromes …
LEXINGTON, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from …
SANTA CLARA, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that it has changed the date of its previously announced …
Array DuraTrack® solar trackers to be installed at one of the largest solar energy projects in the U.S. Project raises Array’s profile in growing Midwest U.S. market and solidifies its global leadership position as a renewable energy solutions partner …
MIDLAND, Texas, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Viper Energy Partners LP (NASDAQ:VNOM) (“Viper” or the “Company”), a subsidiary of Diamondback Energy, Inc. (NASDAQ:FANG) (“Diamondback”), today announced financial and operating results for the third …
– Net revenue was $16.2M for 3Q22 including profit-sharing revenue of $7.4M from KORSUVA® (difelikefalin) injection – – Strong demand for KORSUVA injection driven by large dialysis organizations with ~180,000 vials shipped – – FDA meeting scheduled in 4Q22 …
Second quarter SaaS Subscription Revenue grew 47% year-over-year to $25.5 million Second quarter total revenue increased 43% year-over-year to $27.9 million Current SaaS Subscription Remaining Performance Obligations grew 51% year-over-year to $88.7 …
Les revenus tirés des abonnements SaaS pour le deuxième trimestre ont augmenté de 47% par rapport à l’année précédente à 25,5 M$US. Le total des revenus pour le deuxième trimestre a augmenté de 43% par rapport à l’année précédente à 27,9 M$US. La portion …
CHARLOTTESVILLE, Va. and CARMEL, Ind., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company focused on the development of novel targeted therapeutics for Alzheimer’s disease, today …
TULSA, Okla., Nov. 07, 2022 (GLOBE NEWSWIRE) -- AAON, INC. (NASDAQ-AAON), a provider of premier, configurable HVAC solutions that bring long-term value to customers and owners, today announced its results for the third quarter of 2022. Net sales for the …
Disciplined Cost Management Drove Improving Cash Flow Raises Midpoint of 2022 Revenue and Adjusted EBITDA Guidance NASHVILLE, Tenn., Nov. 07, 2022 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the first …
MIDLAND, Texas, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback” or the “Company”) today announced financial and operating results for the third quarter ended September 30, 2022. THIRD QUARTER 2022 HIGHLIGHTS Average …
EDISON, N.J. , Nov. 07, 2022 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) ("Eos"), a leading provider of safe, scalable, efficient, and sustainable zinc-based long duration energy storage systems, today announced financial …
